All-transretinoic acid as a novel therapeutic strategy for Alzheimer’s disease
نویسندگان
چکیده
منابع مشابه
P13: Aquaporins Function as a Novel Therapeutic Strategy for a Variety of Cerebral Disorders
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملUtilizing TH9 cells as a novel therapeutic strategy for malignancies
TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.
متن کاملInhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
RATIONALE The axon-guiding molecules known as semaphorins and their receptors (plexins) regulate the vascular pattern and play an important role in the development of vascular network during embryogenesis. Semaphorin (Sema)3E is one of the class 3 semaphorins, and plexinD1 is known to be its receptor. Although these molecules have a role in embryonic vascular development, it remains unclear whe...
متن کاملGeroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease
Chronic obstructive pulmonary disease (COPD) progresses very slowly and the majority of patients are therefore elderly. COPD is characterized by an abnormal persistent inflammatory response to noxious environmental stimuli and there are increasing evidences for a close relationship between premature aging and chronic inflammatory diseases. Thus, COPD is considered to be a disease of an accelera...
متن کاملInhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.
Lowering low-density lipoprotein cholesterol (LDL-C) levels with statins is a proven strategy for reducing the risk of atherothrombotic cardiovascular disease (CVD). Yet, despite the success of statins in reducing cardiovascular event rates in at-risk patients, many will still experience further events. There is, therefore, a need to develop suitable therapies to reduce this residual risk. Low ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Neurotherapeutics
سال: 2009
ISSN: 1473-7175,1744-8360
DOI: 10.1586/ern.09.86